nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—DRD2—nicotine dependence	0.593	1	CbGaD
Risperidone—Middle insomnia—Varenicline—nicotine dependence	0.00767	0.0338	CcSEcCtD
Risperidone—Initial insomnia—Varenicline—nicotine dependence	0.0069	0.0304	CcSEcCtD
Risperidone—Electrocardiogram ST segment depression—Varenicline—nicotine dependence	0.00555	0.0244	CcSEcCtD
Risperidone—Restless legs syndrome—Varenicline—nicotine dependence	0.00441	0.0194	CcSEcCtD
Risperidone—Joint stiffness—Varenicline—nicotine dependence	0.00417	0.0184	CcSEcCtD
Risperidone—Polydipsia—Varenicline—nicotine dependence	0.00406	0.0179	CcSEcCtD
Risperidone—Respiratory tract congestion—Varenicline—nicotine dependence	0.00345	0.0152	CcSEcCtD
Risperidone—Musculoskeletal chest pain—Varenicline—nicotine dependence	0.00325	0.0143	CcSEcCtD
Risperidone—Drug hypersensitivity—Varenicline—nicotine dependence	0.00313	0.0138	CcSEcCtD
Risperidone—Rash generalised—Varenicline—nicotine dependence	0.00296	0.0131	CcSEcCtD
Risperidone—Paliperidone—DRD2—nicotine dependence	0.0029	0.588	CrCbGaD
Risperidone—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.00257	0.0113	CcSEcCtD
Risperidone—Sinus congestion—Varenicline—nicotine dependence	0.00253	0.0111	CcSEcCtD
Risperidone—Transient ischaemic attack—Varenicline—nicotine dependence	0.0025	0.011	CcSEcCtD
Risperidone—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.00243	0.0107	CcSEcCtD
Risperidone—Suicide—Varenicline—nicotine dependence	0.00243	0.0107	CcSEcCtD
Risperidone—Balance disorder—Varenicline—nicotine dependence	0.0023	0.0101	CcSEcCtD
Risperidone—Sexual dysfunction—Varenicline—nicotine dependence	0.00225	0.0099	CcSEcCtD
Risperidone—Suicide attempt—Varenicline—nicotine dependence	0.00222	0.00978	CcSEcCtD
Risperidone—Gastric ulcer—Varenicline—nicotine dependence	0.00217	0.00955	CcSEcCtD
Risperidone—Completed suicide—Varenicline—nicotine dependence	0.00214	0.00944	CcSEcCtD
Risperidone—Platelet count decreased—Varenicline—nicotine dependence	0.00212	0.00933	CcSEcCtD
Risperidone—Libido increased—Varenicline—nicotine dependence	0.00207	0.00912	CcSEcCtD
Risperidone—Vaginal discharge—Varenicline—nicotine dependence	0.00207	0.00912	CcSEcCtD
Risperidone—Toothache—Varenicline—nicotine dependence	0.00207	0.00912	CcSEcCtD
Risperidone—H1F0—cardiovascular system—nicotine dependence	0.00204	0.0494	CbGeAlD
Risperidone—Iloperidone—DRD2—nicotine dependence	0.00203	0.412	CrCbGaD
Risperidone—Psoriasis—Varenicline—nicotine dependence	0.002	0.00883	CcSEcCtD
Risperidone—DRD4—brain—nicotine dependence	0.00197	0.0475	CbGeAlD
Risperidone—Upset stomach—Varenicline—nicotine dependence	0.00192	0.00847	CcSEcCtD
Risperidone—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.00192	0.00847	CcSEcCtD
Risperidone—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.00187	0.00822	CcSEcCtD
Risperidone—Menstrual disorder—Varenicline—nicotine dependence	0.00185	0.00814	CcSEcCtD
Risperidone—Paranoia—Varenicline—nicotine dependence	0.00185	0.00814	CcSEcCtD
Risperidone—Laryngeal pain—Varenicline—nicotine dependence	0.00185	0.00814	CcSEcCtD
Risperidone—Intestinal obstruction—Varenicline—nicotine dependence	0.00185	0.00814	CcSEcCtD
Risperidone—Haematemesis—Varenicline—nicotine dependence	0.00181	0.00799	CcSEcCtD
Risperidone—Delusion—Varenicline—nicotine dependence	0.00178	0.00784	CcSEcCtD
Risperidone—Hyperlipidaemia—Varenicline—nicotine dependence	0.00175	0.0077	CcSEcCtD
Risperidone—Mania—Varenicline—nicotine dependence	0.00173	0.00763	CcSEcCtD
Risperidone—Menorrhagia—Varenicline—nicotine dependence	0.0017	0.0075	CcSEcCtD
Risperidone—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00167	0.00737	CcSEcCtD
Risperidone—HTR1B—cardiovascular system—nicotine dependence	0.00164	0.0395	CbGeAlD
Risperidone—Fungal infection—Varenicline—nicotine dependence	0.00163	0.00718	CcSEcCtD
Risperidone—Gingivitis—Varenicline—nicotine dependence	0.0016	0.00707	CcSEcCtD
Risperidone—H1F0—midbrain—nicotine dependence	0.0016	0.0385	CbGeAlD
Risperidone—HTR1D—cardiovascular system—nicotine dependence	0.00158	0.0382	CbGeAlD
Risperidone—DRD1—midbrain—nicotine dependence	0.00158	0.0381	CbGeAlD
Risperidone—Rhinorrhoea—Varenicline—nicotine dependence	0.00155	0.00685	CcSEcCtD
Risperidone—Glycosuria—Varenicline—nicotine dependence	0.00155	0.00685	CcSEcCtD
Risperidone—Dysphonia—Varenicline—nicotine dependence	0.00153	0.00674	CcSEcCtD
Risperidone—Endocrine disorder—Varenicline—nicotine dependence	0.00152	0.00669	CcSEcCtD
Risperidone—Acne—Varenicline—nicotine dependence	0.0015	0.00659	CcSEcCtD
Risperidone—HTR2B—cardiovascular system—nicotine dependence	0.00147	0.0356	CbGeAlD
Risperidone—Disturbance in attention—Varenicline—nicotine dependence	0.00145	0.0064	CcSEcCtD
Risperidone—Aggression—Varenicline—nicotine dependence	0.00143	0.00631	CcSEcCtD
Risperidone—Chest discomfort—Varenicline—nicotine dependence	0.00142	0.00627	CcSEcCtD
Risperidone—Viral infection—Varenicline—nicotine dependence	0.00139	0.00614	CcSEcCtD
Risperidone—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00139	0.00614	CcSEcCtD
Risperidone—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.00139	0.00614	CcSEcCtD
Risperidone—DRD3—brain—nicotine dependence	0.00138	0.0334	CbGeAlD
Risperidone—Thinking abnormal—Varenicline—nicotine dependence	0.00138	0.00606	CcSEcCtD
Risperidone—Lacrimation increased—Varenicline—nicotine dependence	0.00137	0.00602	CcSEcCtD
Risperidone—Leukocytosis—Varenicline—nicotine dependence	0.00134	0.0059	CcSEcCtD
Risperidone—Dysarthria—Varenicline—nicotine dependence	0.00133	0.00587	CcSEcCtD
Risperidone—HTR1A—cardiovascular system—nicotine dependence	0.00132	0.0319	CbGeAlD
Risperidone—Coordination abnormal—Varenicline—nicotine dependence	0.00128	0.00565	CcSEcCtD
Risperidone—HTR1B—midbrain—nicotine dependence	0.00128	0.0308	CbGeAlD
Risperidone—Musculoskeletal pain—Varenicline—nicotine dependence	0.00127	0.00562	CcSEcCtD
Risperidone—HTR7—cardiovascular system—nicotine dependence	0.00126	0.0305	CbGeAlD
Risperidone—Pulmonary embolism—Varenicline—nicotine dependence	0.00126	0.00555	CcSEcCtD
Risperidone—Eructation—Varenicline—nicotine dependence	0.00124	0.00545	CcSEcCtD
Risperidone—HTR1D—midbrain—nicotine dependence	0.00124	0.0299	CbGeAlD
Risperidone—HTR2C—midbrain—nicotine dependence	0.00122	0.0296	CbGeAlD
Risperidone—Salivary hypersecretion—Varenicline—nicotine dependence	0.00122	0.00539	CcSEcCtD
Risperidone—Influenza like illness—Varenicline—nicotine dependence	0.00122	0.00539	CcSEcCtD
Risperidone—Nightmare—Varenicline—nicotine dependence	0.00122	0.00536	CcSEcCtD
Risperidone—ADRA1A—cardiovascular system—nicotine dependence	0.00122	0.0294	CbGeAlD
Risperidone—Photophobia—Varenicline—nicotine dependence	0.00118	0.00521	CcSEcCtD
Risperidone—KCNH2—cardiovascular system—nicotine dependence	0.00117	0.0284	CbGeAlD
Risperidone—Dry eye—Varenicline—nicotine dependence	0.00116	0.00512	CcSEcCtD
Risperidone—Oesophagitis—Varenicline—nicotine dependence	0.00115	0.00507	CcSEcCtD
Risperidone—Urine output increased—Varenicline—nicotine dependence	0.00114	0.00502	CcSEcCtD
Risperidone—Mouth ulceration—Varenicline—nicotine dependence	0.00114	0.00502	CcSEcCtD
Risperidone—Hypertonia—Varenicline—nicotine dependence	0.0011	0.00486	CcSEcCtD
Risperidone—Mental disability—Varenicline—nicotine dependence	0.00109	0.00481	CcSEcCtD
Risperidone—Euphoric mood—Varenicline—nicotine dependence	0.00108	0.00477	CcSEcCtD
Risperidone—Lymphadenopathy—Varenicline—nicotine dependence	0.00107	0.00472	CcSEcCtD
Risperidone—ADRA1B—brain—nicotine dependence	0.00106	0.0257	CbGeAlD
Risperidone—Sleep disorder—Varenicline—nicotine dependence	0.00106	0.00465	CcSEcCtD
Risperidone—Diabetes mellitus—Varenicline—nicotine dependence	0.00105	0.00463	CcSEcCtD
Risperidone—Polyuria—Varenicline—nicotine dependence	0.00104	0.00459	CcSEcCtD
Risperidone—HTR1A—midbrain—nicotine dependence	0.00103	0.0249	CbGeAlD
Risperidone—Deafness—Varenicline—nicotine dependence	0.00102	0.0045	CcSEcCtD
Risperidone—Eczema—Varenicline—nicotine dependence	0.00102	0.00448	CcSEcCtD
Risperidone—Eye pain—Varenicline—nicotine dependence	0.00101	0.00446	CcSEcCtD
Risperidone—H1F0—brain—nicotine dependence	0.001	0.0242	CbGeAlD
Risperidone—Renal failure acute—Varenicline—nicotine dependence	0.00099	0.00436	CcSEcCtD
Risperidone—DRD1—brain—nicotine dependence	0.00099	0.0239	CbGeAlD
Risperidone—Libido decreased—Varenicline—nicotine dependence	0.000986	0.00434	CcSEcCtD
Risperidone—HTR7—midbrain—nicotine dependence	0.000985	0.0238	CbGeAlD
Risperidone—Amnesia—Varenicline—nicotine dependence	0.000973	0.00429	CcSEcCtD
Risperidone—Increased appetite—Varenicline—nicotine dependence	0.000973	0.00429	CcSEcCtD
Risperidone—Atrial fibrillation—Varenicline—nicotine dependence	0.000965	0.00425	CcSEcCtD
Risperidone—Thirst—Varenicline—nicotine dependence	0.000961	0.00423	CcSEcCtD
Risperidone—Arthritis—Varenicline—nicotine dependence	0.000941	0.00414	CcSEcCtD
Risperidone—Hypoglycaemia—Varenicline—nicotine dependence	0.000937	0.00413	CcSEcCtD
Risperidone—Lethargy—Varenicline—nicotine dependence	0.000933	0.00411	CcSEcCtD
Risperidone—Cerebrovascular accident—Varenicline—nicotine dependence	0.000933	0.00411	CcSEcCtD
Risperidone—DRD2—midbrain—nicotine dependence	0.000931	0.0225	CbGeAlD
Risperidone—KCNH2—midbrain—nicotine dependence	0.000917	0.0222	CbGeAlD
Risperidone—Osteoarthritis—Varenicline—nicotine dependence	0.000914	0.00403	CcSEcCtD
Risperidone—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.000914	0.00403	CcSEcCtD
Risperidone—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.000907	0.004	CcSEcCtD
Risperidone—ADRA2C—midbrain—nicotine dependence	0.000905	0.0219	CbGeAlD
Risperidone—Migraine—Varenicline—nicotine dependence	0.0009	0.00396	CcSEcCtD
Risperidone—Affect lability—Varenicline—nicotine dependence	0.0009	0.00396	CcSEcCtD
Risperidone—Psychotic disorder—Varenicline—nicotine dependence	0.000893	0.00393	CcSEcCtD
Risperidone—Urinary retention—Varenicline—nicotine dependence	0.000869	0.00383	CcSEcCtD
Risperidone—Mood swings—Varenicline—nicotine dependence	0.000866	0.00381	CcSEcCtD
Risperidone—Dry skin—Varenicline—nicotine dependence	0.000838	0.00369	CcSEcCtD
Risperidone—Abdominal pain upper—Varenicline—nicotine dependence	0.000835	0.00368	CcSEcCtD
Risperidone—Hypokalaemia—Varenicline—nicotine dependence	0.000832	0.00367	CcSEcCtD
Risperidone—Breast disorder—Varenicline—nicotine dependence	0.000826	0.00364	CcSEcCtD
Risperidone—Nasopharyngitis—Varenicline—nicotine dependence	0.000818	0.0036	CcSEcCtD
Risperidone—Gastritis—Varenicline—nicotine dependence	0.000809	0.00356	CcSEcCtD
Risperidone—HTR1B—brain—nicotine dependence	0.000802	0.0194	CbGeAlD
Risperidone—Abdominal distension—Varenicline—nicotine dependence	0.000796	0.0035	CcSEcCtD
Risperidone—Dysphagia—Varenicline—nicotine dependence	0.00079	0.00348	CcSEcCtD
Risperidone—Asthma—Varenicline—nicotine dependence	0.00079	0.00348	CcSEcCtD
Risperidone—HTR2A—cardiovascular system—nicotine dependence	0.000786	0.019	CbGeAlD
Risperidone—HTR1D—brain—nicotine dependence	0.000777	0.0188	CbGeAlD
Risperidone—Angina pectoris—Varenicline—nicotine dependence	0.00077	0.00339	CcSEcCtD
Risperidone—HTR2C—brain—nicotine dependence	0.000769	0.0186	CbGeAlD
Risperidone—Bronchitis—Varenicline—nicotine dependence	0.00076	0.00335	CcSEcCtD
Risperidone—Abdominal discomfort—Varenicline—nicotine dependence	0.000758	0.00334	CcSEcCtD
Risperidone—Pollakiuria—Varenicline—nicotine dependence	0.00073	0.00322	CcSEcCtD
Risperidone—Erectile dysfunction—Varenicline—nicotine dependence	0.000728	0.00321	CcSEcCtD
Risperidone—HTR2B—brain—nicotine dependence	0.000723	0.0175	CbGeAlD
Risperidone—ADRA2A—midbrain—nicotine dependence	0.000722	0.0174	CbGeAlD
Risperidone—Photosensitivity reaction—Varenicline—nicotine dependence	0.000721	0.00318	CcSEcCtD
Risperidone—Weight increased—Varenicline—nicotine dependence	0.000719	0.00317	CcSEcCtD
Risperidone—Hyperglycaemia—Varenicline—nicotine dependence	0.000713	0.00314	CcSEcCtD
Risperidone—Infestation NOS—Varenicline—nicotine dependence	0.000705	0.0031	CcSEcCtD
Risperidone—Infestation—Varenicline—nicotine dependence	0.000705	0.0031	CcSEcCtD
Risperidone—Depression—Varenicline—nicotine dependence	0.000703	0.00309	CcSEcCtD
Risperidone—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.000699	0.00308	CcSEcCtD
Risperidone—Acute coronary syndrome—Varenicline—nicotine dependence	0.000695	0.00306	CcSEcCtD
Risperidone—Myocardial infarction—Varenicline—nicotine dependence	0.000691	0.00304	CcSEcCtD
Risperidone—Stomatitis—Varenicline—nicotine dependence	0.000687	0.00303	CcSEcCtD
Risperidone—Conjunctivitis—Varenicline—nicotine dependence	0.000685	0.00302	CcSEcCtD
Risperidone—Hepatobiliary disease—Varenicline—nicotine dependence	0.000666	0.00294	CcSEcCtD
Risperidone—Epistaxis—Varenicline—nicotine dependence	0.000665	0.00293	CcSEcCtD
Risperidone—Sinusitis—Varenicline—nicotine dependence	0.000661	0.00291	CcSEcCtD
Risperidone—HTR1A—brain—nicotine dependence	0.000647	0.0156	CbGeAlD
Risperidone—Bradycardia—Varenicline—nicotine dependence	0.000644	0.00284	CcSEcCtD
Risperidone—Hypoaesthesia—Varenicline—nicotine dependence	0.000629	0.00277	CcSEcCtD
Risperidone—Urinary tract disorder—Varenicline—nicotine dependence	0.000625	0.00275	CcSEcCtD
Risperidone—Oedema peripheral—Varenicline—nicotine dependence	0.000623	0.00274	CcSEcCtD
Risperidone—Connective tissue disorder—Varenicline—nicotine dependence	0.000622	0.00274	CcSEcCtD
Risperidone—Urethral disorder—Varenicline—nicotine dependence	0.00062	0.00273	CcSEcCtD
Risperidone—HTR7—brain—nicotine dependence	0.000619	0.0149	CbGeAlD
Risperidone—HTR2A—midbrain—nicotine dependence	0.000614	0.0148	CbGeAlD
Risperidone—Visual impairment—Varenicline—nicotine dependence	0.00061	0.00268	CcSEcCtD
Risperidone—Erythema multiforme—Varenicline—nicotine dependence	0.000598	0.00263	CcSEcCtD
Risperidone—ADRA1A—brain—nicotine dependence	0.000597	0.0144	CbGeAlD
Risperidone—Eye disorder—Varenicline—nicotine dependence	0.000591	0.0026	CcSEcCtD
Risperidone—Tinnitus—Varenicline—nicotine dependence	0.00059	0.0026	CcSEcCtD
Risperidone—Cardiac disorder—Varenicline—nicotine dependence	0.000587	0.00259	CcSEcCtD
Risperidone—DRD2—brain—nicotine dependence	0.000585	0.0141	CbGeAlD
Risperidone—KCNH2—brain—nicotine dependence	0.000576	0.0139	CbGeAlD
Risperidone—Angiopathy—Varenicline—nicotine dependence	0.000574	0.00253	CcSEcCtD
Risperidone—Immune system disorder—Varenicline—nicotine dependence	0.000571	0.00252	CcSEcCtD
Risperidone—Mediastinal disorder—Varenicline—nicotine dependence	0.00057	0.00251	CcSEcCtD
Risperidone—ADRA2C—brain—nicotine dependence	0.000569	0.0137	CbGeAlD
Risperidone—Chills—Varenicline—nicotine dependence	0.000568	0.0025	CcSEcCtD
Risperidone—Arrhythmia—Varenicline—nicotine dependence	0.000565	0.00249	CcSEcCtD
Risperidone—Mental disorder—Varenicline—nicotine dependence	0.000554	0.00244	CcSEcCtD
Risperidone—Erythema—Varenicline—nicotine dependence	0.000551	0.00243	CcSEcCtD
Risperidone—Malnutrition—Varenicline—nicotine dependence	0.000551	0.00243	CcSEcCtD
Risperidone—Flatulence—Varenicline—nicotine dependence	0.000543	0.00239	CcSEcCtD
Risperidone—Dysgeusia—Varenicline—nicotine dependence	0.000539	0.00237	CcSEcCtD
Risperidone—Back pain—Varenicline—nicotine dependence	0.000533	0.00235	CcSEcCtD
Risperidone—Muscle spasms—Varenicline—nicotine dependence	0.000529	0.00233	CcSEcCtD
Risperidone—Vision blurred—Varenicline—nicotine dependence	0.000519	0.00229	CcSEcCtD
Risperidone—Tremor—Varenicline—nicotine dependence	0.000516	0.00227	CcSEcCtD
Risperidone—ABCB1—cardiovascular system—nicotine dependence	0.000515	0.0124	CbGeAlD
Risperidone—Ill-defined disorder—Varenicline—nicotine dependence	0.000511	0.00225	CcSEcCtD
Risperidone—Anaemia—Varenicline—nicotine dependence	0.000509	0.00224	CcSEcCtD
Risperidone—Agitation—Varenicline—nicotine dependence	0.000506	0.00223	CcSEcCtD
Risperidone—Angioedema—Varenicline—nicotine dependence	0.000503	0.00222	CcSEcCtD
Risperidone—Malaise—Varenicline—nicotine dependence	0.000497	0.00219	CcSEcCtD
Risperidone—Vertigo—Varenicline—nicotine dependence	0.000495	0.00218	CcSEcCtD
Risperidone—Syncope—Varenicline—nicotine dependence	0.000494	0.00217	CcSEcCtD
Risperidone—Palpitations—Varenicline—nicotine dependence	0.000487	0.00214	CcSEcCtD
Risperidone—Loss of consciousness—Varenicline—nicotine dependence	0.000484	0.00213	CcSEcCtD
Risperidone—Cough—Varenicline—nicotine dependence	0.000481	0.00212	CcSEcCtD
Risperidone—Convulsion—Varenicline—nicotine dependence	0.000477	0.0021	CcSEcCtD
Risperidone—Hypertension—Varenicline—nicotine dependence	0.000475	0.00209	CcSEcCtD
Risperidone—Myalgia—Varenicline—nicotine dependence	0.000469	0.00206	CcSEcCtD
Risperidone—Arthralgia—Varenicline—nicotine dependence	0.000469	0.00206	CcSEcCtD
Risperidone—Chest pain—Varenicline—nicotine dependence	0.000469	0.00206	CcSEcCtD
Risperidone—Anxiety—Varenicline—nicotine dependence	0.000467	0.00206	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.000466	0.00205	CcSEcCtD
Risperidone—Discomfort—Varenicline—nicotine dependence	0.000463	0.00204	CcSEcCtD
Risperidone—HRH1—brain—nicotine dependence	0.000462	0.0112	CbGeAlD
Risperidone—Dry mouth—Varenicline—nicotine dependence	0.000458	0.00202	CcSEcCtD
Risperidone—ADRA2A—brain—nicotine dependence	0.000454	0.011	CbGeAlD
Risperidone—Oedema—Varenicline—nicotine dependence	0.000449	0.00198	CcSEcCtD
Risperidone—Infection—Varenicline—nicotine dependence	0.000446	0.00197	CcSEcCtD
Risperidone—Shock—Varenicline—nicotine dependence	0.000442	0.00195	CcSEcCtD
Risperidone—Nervous system disorder—Varenicline—nicotine dependence	0.000441	0.00194	CcSEcCtD
Risperidone—Thrombocytopenia—Varenicline—nicotine dependence	0.00044	0.00194	CcSEcCtD
Risperidone—Tachycardia—Varenicline—nicotine dependence	0.000439	0.00193	CcSEcCtD
Risperidone—Skin disorder—Varenicline—nicotine dependence	0.000437	0.00192	CcSEcCtD
Risperidone—Hyperhidrosis—Varenicline—nicotine dependence	0.000434	0.00191	CcSEcCtD
Risperidone—Anorexia—Varenicline—nicotine dependence	0.000428	0.00189	CcSEcCtD
Risperidone—Hypotension—Varenicline—nicotine dependence	0.00042	0.00185	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.000409	0.0018	CcSEcCtD
Risperidone—Insomnia—Varenicline—nicotine dependence	0.000406	0.00179	CcSEcCtD
Risperidone—ABCB1—midbrain—nicotine dependence	0.000402	0.00972	CbGeAlD
Risperidone—Dyspnoea—Varenicline—nicotine dependence	0.000401	0.00176	CcSEcCtD
Risperidone—Somnolence—Varenicline—nicotine dependence	0.0004	0.00176	CcSEcCtD
Risperidone—Dyspepsia—Varenicline—nicotine dependence	0.000396	0.00174	CcSEcCtD
Risperidone—Decreased appetite—Varenicline—nicotine dependence	0.000391	0.00172	CcSEcCtD
Risperidone—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000388	0.00171	CcSEcCtD
Risperidone—Fatigue—Varenicline—nicotine dependence	0.000387	0.00171	CcSEcCtD
Risperidone—HTR2A—brain—nicotine dependence	0.000386	0.00932	CbGeAlD
Risperidone—Constipation—Varenicline—nicotine dependence	0.000384	0.00169	CcSEcCtD
Risperidone—Pain—Varenicline—nicotine dependence	0.000384	0.00169	CcSEcCtD
Risperidone—Feeling abnormal—Varenicline—nicotine dependence	0.00037	0.00163	CcSEcCtD
Risperidone—Gastrointestinal pain—Varenicline—nicotine dependence	0.000367	0.00162	CcSEcCtD
Risperidone—Urticaria—Varenicline—nicotine dependence	0.000357	0.00157	CcSEcCtD
Risperidone—Abdominal pain—Varenicline—nicotine dependence	0.000355	0.00156	CcSEcCtD
Risperidone—Body temperature increased—Varenicline—nicotine dependence	0.000355	0.00156	CcSEcCtD
Risperidone—CYP2D6—brain—nicotine dependence	0.000352	0.00849	CbGeAlD
Risperidone—Hypersensitivity—Varenicline—nicotine dependence	0.000331	0.00146	CcSEcCtD
Risperidone—Asthenia—Varenicline—nicotine dependence	0.000322	0.00142	CcSEcCtD
Risperidone—Pruritus—Varenicline—nicotine dependence	0.000318	0.0014	CcSEcCtD
Risperidone—Diarrhoea—Varenicline—nicotine dependence	0.000307	0.00135	CcSEcCtD
Risperidone—Dizziness—Varenicline—nicotine dependence	0.000297	0.00131	CcSEcCtD
Risperidone—Vomiting—Varenicline—nicotine dependence	0.000286	0.00126	CcSEcCtD
Risperidone—Rash—Varenicline—nicotine dependence	0.000283	0.00125	CcSEcCtD
Risperidone—Dermatitis—Varenicline—nicotine dependence	0.000283	0.00125	CcSEcCtD
Risperidone—Headache—Varenicline—nicotine dependence	0.000282	0.00124	CcSEcCtD
Risperidone—Nausea—Varenicline—nicotine dependence	0.000267	0.00118	CcSEcCtD
Risperidone—ABCB1—brain—nicotine dependence	0.000253	0.00611	CbGeAlD
Risperidone—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000116	0.000867	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000114	0.000857	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.000112	0.000844	CbGpPWpGaD
Risperidone—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000112	0.000842	CbGpPWpGaD
Risperidone—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000112	0.000838	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—FGD1—nicotine dependence	0.000111	0.000834	CbGpPWpGaD
Risperidone—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00011	0.000828	CbGpPWpGaD
Risperidone—HTR7—GPCR ligand binding—DRD2—nicotine dependence	0.00011	0.000822	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TAS2R16—nicotine dependence	0.000109	0.000817	CbGpPWpGaD
Risperidone—HTR1D—GPCR ligand binding—DRD2—nicotine dependence	0.000109	0.000816	CbGpPWpGaD
Risperidone—ADRA2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000109	0.000815	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000108	0.000812	CbGpPWpGaD
Risperidone—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000107	0.000806	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000107	0.000806	CbGpPWpGaD
Risperidone—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000107	0.000805	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000107	0.000805	CbGpPWpGaD
Risperidone—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.000107	0.000802	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000107	0.000801	CbGpPWpGaD
Risperidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000107	0.0008	CbGpPWpGaD
Risperidone—HTR1B—GPCR ligand binding—DRD2—nicotine dependence	0.000107	0.000799	CbGpPWpGaD
Risperidone—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000106	0.000796	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000106	0.000795	CbGpPWpGaD
Risperidone—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000105	0.000791	CbGpPWpGaD
Risperidone—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000105	0.00079	CbGpPWpGaD
Risperidone—DRD4—GPCR ligand binding—DRD2—nicotine dependence	0.000105	0.000787	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TAS2R16—nicotine dependence	0.000104	0.000783	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—FGD1—nicotine dependence	0.000104	0.000779	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000104	0.000778	CbGpPWpGaD
Risperidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000103	0.000774	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.000102	0.000766	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000102	0.000766	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	0.000102	0.000764	CbGpPWpGaD
Risperidone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000101	0.000762	CbGpPWpGaD
Risperidone—HTR2B—GPCR ligand binding—DRD2—nicotine dependence	0.0001	0.000751	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	9.99e-05	0.00075	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TAS2R16—nicotine dependence	9.95e-05	0.000747	CbGpPWpGaD
Risperidone—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	9.85e-05	0.00074	CbGpPWpGaD
Risperidone—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	9.78e-05	0.000734	CbGpPWpGaD
Risperidone—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	9.7e-05	0.000728	CbGpPWpGaD
Risperidone—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	9.68e-05	0.000726	CbGpPWpGaD
Risperidone—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	9.49e-05	0.000713	CbGpPWpGaD
Risperidone—DRD1—GPCR ligand binding—DRD2—nicotine dependence	9.44e-05	0.000708	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—FGD1—nicotine dependence	9.41e-05	0.000707	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TAS2R16—nicotine dependence	9.39e-05	0.000704	CbGpPWpGaD
Risperidone—DRD3—GPCR ligand binding—DRD2—nicotine dependence	9.31e-05	0.000699	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	9.28e-05	0.000696	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	9.26e-05	0.000695	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TAS2R16—nicotine dependence	9.26e-05	0.000695	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—FGD1—nicotine dependence	9.24e-05	0.000694	CbGpPWpGaD
Risperidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.21e-05	0.000691	CbGpPWpGaD
Risperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.19e-05	0.000689	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	9.07e-05	0.000681	CbGpPWpGaD
Risperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.01e-05	0.000677	CbGpPWpGaD
Risperidone—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	8.82e-05	0.000662	CbGpPWpGaD
Risperidone—HTR7—GPCR downstream signaling—OPRM1—nicotine dependence	8.56e-05	0.000642	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—FGD1—nicotine dependence	8.55e-05	0.000641	CbGpPWpGaD
Risperidone—HTR1D—GPCR downstream signaling—OPRM1—nicotine dependence	8.5e-05	0.000638	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—FGD1—nicotine dependence	8.49e-05	0.000637	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	8.43e-05	0.000632	CbGpPWpGaD
Risperidone—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	8.41e-05	0.000631	CbGpPWpGaD
Risperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	8.38e-05	0.000629	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	8.36e-05	0.000628	CbGpPWpGaD
Risperidone—HTR1B—GPCR downstream signaling—OPRM1—nicotine dependence	8.33e-05	0.000625	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—FGD1—nicotine dependence	8.31e-05	0.000624	CbGpPWpGaD
Risperidone—DRD4—GPCR downstream signaling—OPRM1—nicotine dependence	8.19e-05	0.000615	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—FGD1—nicotine dependence	8.18e-05	0.000614	CbGpPWpGaD
Risperidone—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	8.11e-05	0.000609	CbGpPWpGaD
Risperidone—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	8.07e-05	0.000606	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	8.07e-05	0.000606	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	8.03e-05	0.000603	CbGpPWpGaD
Risperidone—ADRA2C—GPCR ligand binding—DRD2—nicotine dependence	7.85e-05	0.000589	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—OPRM1—nicotine dependence	7.82e-05	0.000587	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TAS2R16—nicotine dependence	7.81e-05	0.000586	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—FGD1—nicotine dependence	7.81e-05	0.000586	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—OPRM1—nicotine dependence	7.77e-05	0.000583	CbGpPWpGaD
Risperidone—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	7.73e-05	0.00058	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—OPRM1—nicotine dependence	7.72e-05	0.00058	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	7.69e-05	0.000577	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—OPRM1—nicotine dependence	7.56e-05	0.000567	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—AKR1B10—nicotine dependence	7.55e-05	0.000567	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—AKR1B10—nicotine dependence	7.5e-05	0.000563	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—OPRM1—nicotine dependence	7.44e-05	0.000558	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—OPRM1—nicotine dependence	7.38e-05	0.000554	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—FGD1—nicotine dependence	7.37e-05	0.000553	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—AKR1B10—nicotine dependence	7.34e-05	0.000551	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—OPRM1—nicotine dependence	7.28e-05	0.000546	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—FGD1—nicotine dependence	7.27e-05	0.000545	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—AKR1B10—nicotine dependence	7.23e-05	0.000542	CbGpPWpGaD
Risperidone—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	7.22e-05	0.000542	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	7.1e-05	0.000533	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	7.09e-05	0.000532	CbGpPWpGaD
Risperidone—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	7.01e-05	0.000526	CbGpPWpGaD
Risperidone—HRH1—GPCR ligand binding—DRD2—nicotine dependence	7e-05	0.000525	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	6.97e-05	0.000523	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	6.96e-05	0.000522	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	6.9e-05	0.000518	CbGpPWpGaD
Risperidone—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	6.86e-05	0.000515	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	6.83e-05	0.000512	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—OPRM1—nicotine dependence	6.7e-05	0.000503	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—OPRM1—nicotine dependence	6.61e-05	0.000496	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	6.57e-05	0.000493	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	6.56e-05	0.000492	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—AKR1B10—nicotine dependence	6.51e-05	0.000488	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—AKR1B10—nicotine dependence	6.42e-05	0.000482	CbGpPWpGaD
Risperidone—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	6.38e-05	0.000479	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	6.34e-05	0.000476	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	6.34e-05	0.000476	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—FGD1—nicotine dependence	6.33e-05	0.000475	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	6.31e-05	0.000474	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—FGD1—nicotine dependence	6.3e-05	0.000473	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—CYP2A7—nicotine dependence	6.2e-05	0.000465	CbGpPWpGaD
Risperidone—HTR7—GPCR downstream signaling—DRD2—nicotine dependence	6.19e-05	0.000464	CbGpPWpGaD
Risperidone—HTR1D—GPCR downstream signaling—DRD2—nicotine dependence	6.15e-05	0.000461	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	6.14e-05	0.000461	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	6.13e-05	0.00046	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	6.04e-05	0.000453	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	6.03e-05	0.000453	CbGpPWpGaD
Risperidone—HTR1B—GPCR downstream signaling—DRD2—nicotine dependence	6.02e-05	0.000452	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—CYP2A7—nicotine dependence	6.02e-05	0.000452	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	5.97e-05	0.000448	CbGpPWpGaD
Risperidone—DRD4—GPCR downstream signaling—DRD2—nicotine dependence	5.92e-05	0.000445	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	5.8e-05	0.000435	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	5.76e-05	0.000432	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	5.73e-05	0.00043	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	5.65e-05	0.000424	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—DRD2—nicotine dependence	5.62e-05	0.000422	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	5.59e-05	0.00042	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—DRD2—nicotine dependence	5.58e-05	0.000419	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	5.57e-05	0.000418	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	5.57e-05	0.000418	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	5.57e-05	0.000418	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—FGD1—nicotine dependence	5.56e-05	0.000417	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	5.49e-05	0.000412	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	5.48e-05	0.000411	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—FGD1—nicotine dependence	5.47e-05	0.000411	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	5.47e-05	0.00041	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—DRD2—nicotine dependence	5.47e-05	0.00041	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—FGD1—nicotine dependence	5.46e-05	0.00041	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	5.41e-05	0.000406	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—DRD2—nicotine dependence	5.38e-05	0.000404	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	5.37e-05	0.000403	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	5.36e-05	0.000402	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—DRD2—nicotine dependence	5.33e-05	0.0004	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	5.33e-05	0.0004	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—WASF2—nicotine dependence	5.32e-05	0.000399	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—WASF2—nicotine dependence	5.28e-05	0.000397	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—DRD2—nicotine dependence	5.26e-05	0.000395	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—WASF2—nicotine dependence	5.17e-05	0.000388	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	5.14e-05	0.000385	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—WASF1—nicotine dependence	5.1e-05	0.000383	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—WASF2—nicotine dependence	5.09e-05	0.000382	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—WASF1—nicotine dependence	5.07e-05	0.00038	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	5.06e-05	0.00038	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	4.99e-05	0.000374	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	4.98e-05	0.000374	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	4.98e-05	0.000373	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	4.97e-05	0.000373	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—WASF1—nicotine dependence	4.96e-05	0.000372	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	4.91e-05	0.000369	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—CYP2A7—nicotine dependence	4.89e-05	0.000367	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—WASF1—nicotine dependence	4.88e-05	0.000366	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	4.87e-05	0.000366	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—WASF2—nicotine dependence	4.86e-05	0.000365	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—DRD2—nicotine dependence	4.84e-05	0.000363	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	4.83e-05	0.000363	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	4.82e-05	0.000362	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—DRD2—nicotine dependence	4.78e-05	0.000359	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	4.75e-05	0.000357	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	4.73e-05	0.000355	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—WASF1—nicotine dependence	4.66e-05	0.00035	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—OPRM1—nicotine dependence	4.59e-05	0.000345	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	4.59e-05	0.000344	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—WASF2—nicotine dependence	4.58e-05	0.000344	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	4.56e-05	0.000342	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—OPRM1—nicotine dependence	4.56e-05	0.000342	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	4.53e-05	0.00034	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—WASF2—nicotine dependence	4.52e-05	0.000339	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—CYP2A7—nicotine dependence	4.48e-05	0.000336	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—OPRM1—nicotine dependence	4.47e-05	0.000335	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	4.44e-05	0.000333	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	4.4e-05	0.00033	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—OPRM1—nicotine dependence	4.4e-05	0.00033	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—WASF1—nicotine dependence	4.39e-05	0.00033	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	4.37e-05	0.000328	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—WASF1—nicotine dependence	4.34e-05	0.000325	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	4.31e-05	0.000324	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	4.2e-05	0.000315	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	4.16e-05	0.000313	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	4.14e-05	0.000311	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	4.08e-05	0.000306	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	4.03e-05	0.000302	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	3.97e-05	0.000298	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	3.96e-05	0.000297	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—OPRM1—nicotine dependence	3.96e-05	0.000297	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	3.95e-05	0.000297	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—WASF2—nicotine dependence	3.94e-05	0.000296	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—WASF2—nicotine dependence	3.92e-05	0.000294	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	3.91e-05	0.000294	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—OPRM1—nicotine dependence	3.9e-05	0.000293	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	3.88e-05	0.000291	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	3.81e-05	0.000286	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—WASF1—nicotine dependence	3.78e-05	0.000284	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—WASF1—nicotine dependence	3.76e-05	0.000282	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	3.75e-05	0.000282	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	3.66e-05	0.000274	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	3.6e-05	0.000271	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	3.6e-05	0.00027	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	3.6e-05	0.00027	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—DRD2—nicotine dependence	3.59e-05	0.000269	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	3.52e-05	0.000265	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	3.52e-05	0.000264	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—WASF2—nicotine dependence	3.46e-05	0.00026	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—WASF2—nicotine dependence	3.41e-05	0.000256	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	3.4e-05	0.000255	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—WASF2—nicotine dependence	3.4e-05	0.000255	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	3.38e-05	0.000254	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CYP2A7—nicotine dependence	3.38e-05	0.000254	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	3.33e-05	0.00025	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—DRD2—nicotine dependence	3.32e-05	0.000249	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—WASF1—nicotine dependence	3.32e-05	0.000249	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—DRD2—nicotine dependence	3.3e-05	0.000248	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	3.29e-05	0.000247	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	3.27e-05	0.000246	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—WASF1—nicotine dependence	3.26e-05	0.000245	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—WASF1—nicotine dependence	3.26e-05	0.000245	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	3.24e-05	0.000243	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—DRD2—nicotine dependence	3.23e-05	0.000242	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	3.2e-05	0.00024	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CYP2A7—nicotine dependence	3.19e-05	0.000239	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—DRD2—nicotine dependence	3.18e-05	0.000239	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	3.1e-05	0.000233	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—DRD2—nicotine dependence	3.03e-05	0.000228	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—OPRM1—nicotine dependence	2.99e-05	0.000224	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	2.97e-05	0.000223	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	2.94e-05	0.000221	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—OPRM1—nicotine dependence	2.93e-05	0.00022	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	2.88e-05	0.000216	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—DRD2—nicotine dependence	2.86e-05	0.000215	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—DRD2—nicotine dependence	2.82e-05	0.000212	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	2.67e-05	0.000201	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	2.55e-05	0.000191	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—DRD2—nicotine dependence	2.46e-05	0.000185	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—DRD2—nicotine dependence	2.45e-05	0.000184	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	2.38e-05	0.000179	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	2.34e-05	0.000176	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—DRD2—nicotine dependence	2.13e-05	0.00016	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—DRD2—nicotine dependence	2.12e-05	0.000159	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP2A7—nicotine dependence	2.08e-05	0.000156	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	2.08e-05	0.000156	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	1.93e-05	0.000145	CbGpPWpGaD
